Chemed Q2 revenue +8.8% to $673.3M, net income +29% to $67.7M; gross margin up 310bp

Filed July 31, 2026 · Period ending June 30, 2026 · Compared to 10-Q Jul 31, 2025 · ~1 min read

Key Changes

• high

  Revenue rose 8.8% to $673.3M, accelerating from 3.8% growth a year ago, driven by VITAS and Roto-Rooter.

  MD&A: Revenue verify on EDGAR →
• high

  Gross margin expanded to 32.9%, with VITAS margin up from 19.1% to 23.8% and Roto-Rooter from 49.0% to 50.4%.

  MD&A: Gross margin verify on EDGAR →
• high

  Net income rose 29.0% to $67.7M, and diluted EPS jumped 43.7% to $5.13.

  Key Financials view on EDGAR →